RTX (RTX) Q3 24/25 earnings summary

Executive summary

• Achieved solid revenue and profitability growth in Q3 and the first nine months, led by the Enterprise and Healthcare segments, despite currency headwinds and short order cycles limiting forecast visibility.

• Guidance was raised and narrowed for the full year following strong Q3 results and secured Q4 orders, with profitability expectations around zero EBIT.

• Business model leverages long-term partnerships and focuses on secure, reliable wireless communication for critical environments.

• Strategic focus remains on expanding the global customer base and reinforcing long-term growth.

• Currency headwinds from a weaker USD and global tariffs remain uncertainties.

Financial highlights

• Q3 revenue reached DKK 146.9m, up 3.5% YoY; 9M revenue rose 16.7% YoY to DKK 407.3m.

• Gross margin improved to 51.7% in Q3 and 50.7% for 9M, driven by favorable product mix and Healthcare growth.

• Q3 EBITDA was DKK 15.0m (up from DKK 9.4m YoY); 9M EBITDA reached DKK 22.2m (vs. -20.1m YoY).

• Net profit for Q3 was DKK 5.2m; 9M net profit DKK 5.9m (vs. -40.1m YoY).

• Net liquidity at quarter-end was DKK 118.9m, above the targeted range, with free cash flow for 9M at DKK 18.5m.

Outlook and guidance

• Full-year 2024/25 guidance: revenue DKK 530–560m, EBITDA DKK 25–35m, EBIT DKK -5 to 5m.

• Gross margin for the year expected to exceed last year, supported by product mix and Healthcare share.

• Capacity costs anticipated to rise slightly due to salary inflation and strategic hires.

• Inventory reduction expected to continue as component sourcing normalizes.

• Visibility remains short at 3–6 months due to short order cycles.